JP2023540350A5 - - Google Patents
Info
- Publication number
- JP2023540350A5 JP2023540350A5 JP2023515095A JP2023515095A JP2023540350A5 JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5 JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- c6alkyl
- substituted
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074220P | 2020-09-03 | 2020-09-03 | |
| US63/074,220 | 2020-09-03 | ||
| PCT/US2021/049003 WO2022051583A1 (en) | 2020-09-03 | 2021-09-03 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540350A JP2023540350A (ja) | 2023-09-22 |
| JP2023540350A5 true JP2023540350A5 (cg-RX-API-DMAC7.html) | 2024-10-02 |
| JP7811578B2 JP7811578B2 (ja) | 2026-02-05 |
Family
ID=78078371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515095A Active JP7811578B2 (ja) | 2020-09-03 | 2021-09-03 | 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331720A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208465A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7811578B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116635393A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202227433A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022051583A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260083444A (ko) | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| WO2022207935A1 (en) | 2021-04-02 | 2022-10-06 | Orexia Therapeutics Limited | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists |
| JP7833486B2 (ja) * | 2021-05-26 | 2026-03-19 | アルカーメス,インコーポレイテッド | 置換されるカルバメート大環状化合物および関連のある治療方法 |
| WO2023167925A1 (en) * | 2022-03-01 | 2023-09-07 | Orexia Therapeutics Limited | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
| US20260116891A1 (en) * | 2022-04-22 | 2026-04-30 | Teijin Pharma Limited | Oxazepin Derivative |
| CN114716319B (zh) * | 2022-04-28 | 2024-03-26 | 浙江工业大学 | 一种联芳氧基烯酸酯类化合物的合成方法 |
| EP4600242A1 (en) * | 2022-10-07 | 2025-08-13 | Kissei Pharmaceutical Co., Ltd. | Cyclopentane compound |
| TW202432109A (zh) | 2022-10-31 | 2024-08-16 | 日商武田藥品工業股份有限公司 | 食慾素2型受體促效劑之給藥 |
| EP4680611A1 (en) | 2023-03-16 | 2026-01-21 | Takeda Pharmaceutical Company Limited | Macrocyclic heterocycle compounds and use thereof |
| JP2026518313A (ja) | 2023-06-01 | 2026-06-04 | ハー・ルンドベック・アクチエゼルスカベット | スピロ大環状オレキシン2受容体アゴニスト |
| TW202502342A (zh) | 2023-06-02 | 2025-01-16 | 日商武田藥品工業股份有限公司 | 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途 |
| UY40937A (es) * | 2023-10-20 | 2025-04-30 | Teijin Pharma Ltd | Cristal de derivado de oxazepina o cristal de solvato del mismo |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| US20260144795A1 (en) | 2024-11-27 | 2026-05-28 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| US10428023B2 (en) * | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| PE20211700A1 (es) * | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| KR20260083444A (ko) * | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
-
2021
- 2021-09-03 CN CN202180074185.9A patent/CN116635393A/zh active Pending
- 2021-09-03 US US18/024,236 patent/US20230331720A1/en active Pending
- 2021-09-03 JP JP2023515095A patent/JP7811578B2/ja active Active
- 2021-09-03 EP EP21786656.5A patent/EP4208465A1/en active Pending
- 2021-09-03 TW TW110132882A patent/TW202227433A/zh unknown
- 2021-09-03 WO PCT/US2021/049003 patent/WO2022051583A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2660831T3 (es) | Derivados de imidazol condensados útiles como inhibidores de IDO | |
| JP7431900B2 (ja) | (s)-3-(4-((4-(モルホリノメチル)ベンジル)オキシ)-1-オキソイソインドリン-2-イル)ピペリジン-2,6-ジオンの塩及び固体形態、並びにそれらを含有する組成物及び使用方法 | |
| KR101593242B1 (ko) | 6-, 7- 또는 8-치환된 퀴나졸리논 유도체, 및 그를 포함하는 조성물 및 그의 사용 방법 | |
| JP6359563B2 (ja) | 3−(5置換−4−オキソキナゾリン−3(4h)−イル)−3−ジュウテロピペリジン−2,6−ジオン誘導体 | |
| JP2023527575A5 (cg-RX-API-DMAC7.html) | ||
| JP2025507852A5 (cg-RX-API-DMAC7.html) | ||
| JP5959543B2 (ja) | 3−(5−アミノ−2−メチル−4−オキソ−4h−キナゾリン−3−イル)−ピペリジン−2,6−ジオンの固体形態、並びにそれらの医薬組成物及び使用 | |
| JP2018502891A5 (cg-RX-API-DMAC7.html) | ||
| CN103382197A (zh) | N-甲基氨甲基异吲哚化合物和包含它的组合物及其使用方法 | |
| JP2007508361A5 (cg-RX-API-DMAC7.html) | ||
| JP2019529490A5 (cg-RX-API-DMAC7.html) | ||
| RU2011137419A (ru) | Обратные агонисты и антагонисты гистамина н3 и способы их применения | |
| KR102304111B1 (ko) | 베타-클로로시클로펜탄의 친수성 에스테르 전구약물의 이용에 의한 감소된 중심 각막 비후 | |
| JP2014528485A5 (cg-RX-API-DMAC7.html) | ||
| JP2014526469A5 (cg-RX-API-DMAC7.html) | ||
| JPH05320142A (ja) | 中枢神経系に薬理活性をもつ化合物 | |
| JP2009526831A5 (cg-RX-API-DMAC7.html) | ||
| EP3893945A1 (en) | Cromolyn esters and uses thereof | |
| TW201215605A (en) | Manufacturing process for pyrimidine derivatives | |
| WO2014129495A1 (ja) | 眼疾患処置薬 | |
| JP2019532069A5 (cg-RX-API-DMAC7.html) | ||
| RU2019111188A (ru) | Кетоновые ингибиторы лизин-специфичного гингипаина | |
| CN105658634B (zh) | 作为TCR-Nck相互作用的抑制剂的被醇盐取代的色烯衍生物 | |
| KR100292928B1 (ko) | 치환된헥사하이드로벤조페난트리딘 | |
| JP2017525684A5 (cg-RX-API-DMAC7.html) |